Literature DB >> 32185535

ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy.

Konstantinos I Votanopoulos1,2, Aleksander Skardal3,4.   

Abstract

Mesh：

Year:  2020        PMID： 32185535     DOI： 10.1245/s10434-020-08351-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

Authors:  Giovanni Germano; Simona Lamba; Giuseppe Rospo; Ludovic Barault; Alessandro Magrì; Federica Maione; Mariangela Russo; Giovanni Crisafulli; Alice Bartolini; Giulia Lerda; Giulia Siravegna; Benedetta Mussolin; Roberta Frapolli; Monica Montone; Federica Morano; Filippo de Braud; Nabil Amirouchene-Angelozzi; Silvia Marsoni; Maurizio D'Incalci; Armando Orlandi; Enrico Giraudo; Andrea Sartore-Bianchi; Salvatore Siena; Filippo Pietrantonio; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Nature       Date:  2017-11-29       Impact factor: 49.962

2.  Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.

Authors:  Konstantinos I Votanopoulos; Steven Forsythe; Hemamylammal Sivakumar; Andrea Mazzocchi; Julio Aleman; Lance Miller; Edward Levine; Pierre Triozzi; Aleksander Skardal
Journal:  Ann Surg Oncol       Date:  2019-12-19       Impact factor: 5.344

3.  Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.

Authors:  Konstantinos I Votanopoulos; Andrea Mazzocchi; Hemamylammal Sivakumar; Steven Forsythe; Julio Aleman; Edward A Levine; Aleksander Skardal
Journal:  Ann Surg Oncol       Date:  2018-11-09       Impact factor: 5.344

4.  The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors.

Authors:  Andrew A Davis; Vaibhav G Patel
Journal:  J Immunother Cancer       Date:  2019-10-26       Impact factor: 13.751
  4 in total
  4 in total

1.  Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications.

Authors:  Steven D Forsythe; Hemamylammal Sivakumar; Richard A Erali; Nadeem Wajih; Wencheng Li; Perry Shen; Edward A Levine; Katherine E Miller; Aleksander Skardal; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2022-07-03       Impact factor: 4.339

Review 2.  Integrative lymph node-mimicking models created with biomaterials and computational tools to study the immune system.

Authors:  Yufeng Shou; Sarah C Johnson; Ying Jie Quek; Xianlei Li; Andy Tay
Journal:  Mater Today Bio       Date:  2022-04-21

Review 3.  Applications of human organoids in the personalized treatment for digestive diseases.

Authors:  Qinying Wang; Fanying Guo; Yutao Jin; Yanlei Ma
Journal:  Signal Transduct Target Ther       Date:  2022-09-27

Review 4.  Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.

Authors:  Chang Yang; Bai-Rong Xia; Zhao-Cong Zhang; Yong-Jian Zhang; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.